We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

36 hedge funds and large institutions have $34.7M invested in Eledon Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 35 → 36 (+1)

3.84% less ownership

Funds ownership: 58.94% → 55.1% (-3.8%)

33% less capital invested

Capital invested by funds: $52.1M → $34.7M (-$17.4M)

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
6
Closed
4
Calls
$80K
Puts
–
Net Calls
+$80K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.12M
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$353K
3
CM
CM Management
Florida
+$202K
4
Millennium Management
Millennium Management
New York
+$130K
5
BlackRock
BlackRock
New York
+$79.2K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.53M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.53M
3
Morgan Stanley
Morgan Stanley
New York
-$509K
4
Renaissance Technologies
Renaissance Technologies
New York
-$131K
5
VF
Virtu Financial
New York
-$115K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$6.08M +$73.8K +14,585 +1%
LGM
2
Logos Global Management
California
$5.91M – – –
CAM
3
Cormorant Asset Management
Massachusetts
$5.75M – – –
WP
4
Woodline Partners
California
$3.45M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.95M -$4.11K -813 -0.1%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$2.22M -$2.53M -499,740 -50%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$1.9M +$1.12M +221,945 +106%
IC
8
Ikarian Capital
Texas
$1.52M – – –
Two Sigma Advisers
9
Two Sigma Advisers
New York
$563K +$59.2K +11,700 +10%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$558K -$4.29K -848 -0.7%
Two Sigma Investments
11
Two Sigma Investments
New York
$552K +$49.9K +9,869 +9%
CM
12
CM Management
Florida
$507K +$202K +40,000 +53%
EP
13
Eversept Partners
New York
$503K – – –
Ensign Peak Advisors
14
Ensign Peak Advisors
Utah
$340K +$353K +69,872 +967%
BlackRock
15
BlackRock
New York
$279K +$79.2K +15,658 +33%
ISL
16
Ingalls & Snyder LLC
New York
$226K – – –
JE
17
JMAC Enterprises
Pennsylvania
$216K +$276K +54,538 New
State Street
18
State Street
Massachusetts
$178K – – –
Millennium Management
19
Millennium Management
New York
$160K +$130K +25,693 +244%
BFM
20
Boothbay Fund Management
New York
$153K – – –
V
21
Veritable
Delaware
$146K – – –
Northern Trust
22
Northern Trust
Illinois
$133K – – –
AAS
23
Ameritas Advisory Services
Nebraska
$107K +$123K +24,219 New
Envestnet Asset Management
24
Envestnet Asset Management
Illinois
$74K – – –
Mercer Global Advisors
25
Mercer Global Advisors
Colorado
$74K – – –
1
2

ELDN Hedge Fund Activity: Q4 2021 in Review

36 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q4 2021, worth a combined $34.7M — down 33% from $52.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ELDN positions and 4 closed out — a net gain of 1 holder — while 10 added to existing stakes and 6 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $1.12M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $2.53M sold.

  • 36 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q4 2021, up from 35 in Q3 2021.
  • Funds reported $34.7M of Eledon Pharmaceuticals stock for Q4 2021, down 33% quarter-over-quarter.
  • 5 funds opened new Eledon Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +1 holder.
  • The largest Eledon Pharmaceuticals buyer in Q4 2021 was Point72 Asset Management, an estimated $1.12M added.
  • The largest Eledon Pharmaceuticals seller in Q4 2021 was Adage Capital Partners, an estimated $2.53M sold.

Based on aggregated 13F filings for Q4 2021.